Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for Pre-COPD: risk modeling and early intervention
ChiCTR2500101612Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in chronic obstructive pulmonary disease (COPD) comparing N-acetylcysteine treatment group with Placebo group (2 arms). Primary endpoints: Acute exacerbation events and Mortality rate. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
acetylcysteine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR2500101612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101612.